Beta Bionics (BBNX) Competitors $22.90 +0.44 (+1.96%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BBNX vs. TMDX, NVST, SLNO, LIVN, WRBY, LQDA, INSP, LMAT, PRCT, and AORTShould you be buying Beta Bionics stock or one of its competitors? The main competitors of Beta Bionics include TransMedics Group (TMDX), Envista (NVST), Soleno Therapeutics (SLNO), LivaNova (LIVN), Warby Parker (WRBY), Liquidia Technologies (LQDA), Inspire Medical Systems (INSP), LeMaitre Vascular (LMAT), PROCEPT BioRobotics (PRCT), and Artivion (AORT). These companies are all part of the "medical equipment" industry. Beta Bionics vs. Its Competitors TransMedics Group Envista Soleno Therapeutics LivaNova Warby Parker Liquidia Technologies Inspire Medical Systems LeMaitre Vascular PROCEPT BioRobotics Artivion TransMedics Group (NASDAQ:TMDX) and Beta Bionics (NASDAQ:BBNX) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, dividends, analyst recommendations, media sentiment, profitability, risk, institutional ownership and valuation. Does the media favor TMDX or BBNX? In the previous week, TransMedics Group had 8 more articles in the media than Beta Bionics. MarketBeat recorded 12 mentions for TransMedics Group and 4 mentions for Beta Bionics. TransMedics Group's average media sentiment score of 0.59 beat Beta Bionics' score of 0.24 indicating that TransMedics Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment TransMedics Group 3 Very Positive mention(s) 2 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Beta Bionics 1 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do insiders & institutionals hold more shares of TMDX or BBNX? 99.7% of TransMedics Group shares are owned by institutional investors. 7.0% of TransMedics Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Is TMDX or BBNX more profitable? TransMedics Group has a net margin of 13.49% compared to Beta Bionics' net margin of 0.00%. TransMedics Group's return on equity of 28.02% beat Beta Bionics' return on equity.Company Net Margins Return on Equity Return on Assets TransMedics Group13.49% 28.02% 8.64% Beta Bionics N/A N/A N/A Which has preferable earnings & valuation, TMDX or BBNX? TransMedics Group has higher revenue and earnings than Beta Bionics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTransMedics Group$441.54M9.66$35.46M$1.9364.84Beta Bionics$65.12M15.29-$54.76MN/AN/A Do analysts rate TMDX or BBNX? TransMedics Group presently has a consensus price target of $125.40, suggesting a potential upside of 0.20%. Beta Bionics has a consensus price target of $23.33, suggesting a potential upside of 1.89%. Given Beta Bionics' stronger consensus rating and higher probable upside, analysts plainly believe Beta Bionics is more favorable than TransMedics Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TransMedics Group 0 Sell rating(s) 4 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 2.73Beta Bionics 0 Sell rating(s) 4 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 2.75 SummaryTransMedics Group beats Beta Bionics on 9 of the 13 factors compared between the two stocks. Get Beta Bionics News Delivered to You Automatically Sign up to receive the latest news and ratings for BBNX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BBNX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BBNX vs. The Competition Export to ExcelMetricBeta BionicsMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$976.34M$6.76B$5.80B$10.46BDividend YieldN/A1.21%5.61%4.57%P/E RatioN/A26.38348.5626.86Price / Sales15.29197.16549.90125.65Price / CashN/A22.1426.0131.15Price / Book-4.005.0615.536.50Net Income-$54.76M$178.07M$3.29B$271.25M7 Day Performance-9.52%1.53%200.87%3.69%1 Month Performance34.31%6.98%184.38%8.07%1 Year PerformanceN/A19.02%325.51%29.65% Beta Bionics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BBNXBeta Bionics0.922 of 5 stars$22.90+2.0%$23.33+1.9%N/A$976.34M$65.12M0.00294Analyst ForecastTMDXTransMedics Group2.2221 of 5 stars$116.99+8.5%$122.11+4.4%-25.9%$3.67B$441.54M60.62210NVSTEnvista3.7578 of 5 stars$21.61+4.0%$20.92-3.2%+10.1%$3.45B$2.51B67.5312,300Positive NewsSLNOSoleno Therapeutics4.4274 of 5 stars$56.72-5.5%$115.09+102.9%+6.1%$3.19BN/A-13.7030LIVNLivaNova2.7297 of 5 stars$57.34+1.5%$59.71+4.1%+8.4%$3.09B$1.25B-14.742,900Positive NewsWRBYWarby Parker1.4371 of 5 stars$27.56+2.0%$24.06-12.7%+99.4%$2.84B$771.32M-393.663,780Positive NewsInsider TradeLQDALiquidia Technologies3.9385 of 5 stars$27.00-1.1%$32.11+18.9%+139.0%$2.35B$14M-15.8850INSPInspire Medical Systems4.8456 of 5 stars$82.62+4.9%$164.50+99.1%-62.5%$2.33B$802.80M47.761,246Analyst ForecastGap DownLMATLeMaitre Vascular3.0654 of 5 stars$94.23+1.7%$97.60+3.6%+2.5%$2.10B$234.64M45.74490Positive NewsPRCTPROCEPT BioRobotics2.7572 of 5 stars$38.64+3.0%$73.22+89.5%-56.0%$2.09B$224.50M-24.93430Positive NewsAORTArtivion2.5653 of 5 stars$42.26+3.0%$40.63-3.8%+61.0%$1.94B$388.54M-100.621,600Positive News Related Companies and Tools Related Companies TransMedics Group Competitors Envista Competitors Soleno Therapeutics Competitors LivaNova Competitors Warby Parker Competitors Liquidia Technologies Competitors Inspire Medical Systems Competitors LeMaitre Vascular Competitors PROCEPT BioRobotics Competitors Artivion Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BBNX) was last updated on 9/22/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredPrepare for the “Mar-a-Lago Accord” Money ShockWhy Are Wall Street Insiders Moving Their Money to This ONE Asset? Something far more consequential for you...Stansberry Research | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredThe next AI Hype Spike is days away — don’t miss itOn this date, AI could trigger the kind of predictable surge that's already paid out 61%… 158%… and even 382% ...Brownstone Research | SponsoredTrump Devises the Death of the IRS ☠️Trump has just signed an executive order creating America's first-ever National Investment Fund — a game-chang...Angel Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Beta Bionics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Beta Bionics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BBNX Stock Alerts